|
SKP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3107999957972E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52723999999882E-05 |
| Normal-vs-Stage2 |
1.154640E-04 |
| Normal-vs-Stage3 |
1.34740000046207E-07 |
| Normal-vs-Stage4 |
1.49210000000011E-06 |
| Stage1-vs-Stage2 |
9.201600E-01 |
| Stage1-vs-Stage3 |
7.110000E-02 |
| Stage1-vs-Stage4 |
1.500830E-01 |
| Stage2-vs-Stage3 |
2.148200E-01 |
| Stage2-vs-Stage4 |
2.667200E-01 |
| Stage3-vs-Stage4 |
9.661400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05339999945109E-07 |
| Normal-vs-AfricanAmerican |
1.863850E-02 |
| Normal-vs-Asian |
5.50999999999746E-05 |
| Caucasian-vs-AfricanAmerican |
4.076800E-01 |
| Caucasian-vs-Asian |
7.596000E-01 |
| AfricanAmerican-vs-Asian |
3.601800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30390000000025E-06 |
| Normal-vs-Female |
3.97710000488161E-08 |
| Male-vs-Female |
7.272400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.28459999999098E-05 |
| Normal-vs-Age(41-60Yrs) |
1.09200000042442E-07 |
| Normal-vs-Age(61-80Yrs) |
6.75490000046075E-07 |
| Normal-vs-Age(81-100Yrs) |
7.878600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.498800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.514000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.422000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.358600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.999600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.501200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.655500E-03 |
| Classical-VS-Follicular |
7.259200E-01 |
| Classical-VS-Other |
9.014800E-01 |
| Classical-VS-Normal |
1.06020000001372E-06 |
| Tall-VS-Follicular |
2.415800E-02 |
| Tall-VS-Other |
2.153200E-01 |
| Tall-VS-Normal |
2.00869999522624E-08 |
| Follicular-VS-Other |
9.946400E-01 |
| Follicular-VS-Normal |
3.66700000000719E-05 |
| Other-VS-Normal |
6.235500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41850000001664E-06 |
| Normal-vs-N1 |
1.12950000019651E-07 |
| N0-vs-N1 |
7.332100E-02 |
|
|
